Compressive Elastic Dressing Versus TR Band

Summary

Radial approach is widely established in cardiac diagnostic and therapeutic treatments. It has been shown to decrease bleeding, vascular problems, and mortality rates when compared to the femoral approach. It also offers better comfort to patients through early mobility and lowers hospital expenses.

Previously, there were no specific devices for radial artery hemostasis. Many different types of dressings were used in various hospitals with no standardization. This raises the question of whether specific devices surpass dressings in terms of patient comfort, time required to maintain hemostasis, and vascular complications.

The primary goal of this study was to examine the effectiveness of compression dressings and hemostatic wristbands on patients undergoing cardiac procedures via radial approach in terms of patient comfort, time required to maintain hemostasis, and vascular problems.

The hemostatic wristband TR BandR (Terumo Corporation, Tokyo, Japan) was utilized in one group, while compressive elastic dressing, standardized as 13 threads gauze overlapped, opened, longitudinally pleated once and wrapped, making a 5-cm long cylinder, 1-cm in height, was used in the other.

Conditions

• Coronary Artery Disease
• Myocardial Infarction
• Angina, Unstable
• Angina, Stable
• Acute Coronary Syndrome
• STEMI
• NSTEMI
• Ischemic Heart Disease
• Atherosclerotic Cardiovascular Disease
• Chest Pain
• Non ST Elevation Myocardial Infarction

Interventions

PROCEDURE

Compressive Elastic dressing for hemostasis in cardiac procedure using radial approach

Following cardiac procedure using radial approach, compressive elastic dressing, standardized as 13 threads gauze overlapped, opened, longitudinally pleated once and wrapped, making a 5-cm long cylinder, 1-cm in height, fixed with elastic crepe bandage was used to achieve hemostasis.

PROCEDURE

Wristband TR band for hemostasis in cardiac procedure using radial approach

Following cardiac procedure using radial approach, hemostatic wristband TR BandR (Terumo Corporation, Tokyo, Japan) was utilized was used to achieve hemostasis.

Sponsors & Collaborators

• An-Najah National University

  lead OTHER

Principal Investigators

• Yunis A Daralammouri · An-Najah National University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-08-01

Primary Completion

2021-01-01

Completion

2021-05-01

Countries

• Palestinian Territories

Study Locations